| Characteristics, treatment, and outcomes of Myasthenia Gravis in COVID-19 patients: A systematic review AS Abbas, N Hardy, S Ghozy, M Dibas, G Paranjape, KW Evanson, ... Clinical Neurology and Neurosurgery 213, 107140, 2022 | 28 | 2022 |
| Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis N Hardy, CTR Vegivinti, M Mehta, J Thurnham, A Mebane, JM Pederson, ... Clinical and Experimental Medicine 23 (6), 1945-1959, 2023 | 14 | 2023 |
| Meta-analysis on impact of rituximab in patients with hematological malignancies with covid-19 infection CTR Vegivinti, TN Musunuru, RK Thakur, VK Kakumani, AK Mehta, ... Blood 140 (Supplement 1), 13189-13190, 2022 | 2 | 2022 |
| Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis CTR Vegivinti, TN Musunuru, SR Jitta, M Mehta, J Shivkumar, RK Thakur, ... Blood 140 (Supplement 1), 13218-13219, 2022 | 1 | 2022 |
| End Organ Affection in Sickle Cell Disease T Bathla, S Lotfollahzadeh, M Quisel, M Mehta, M Malikova, VC Chitalia Cells 2024 13 (11), 934, 2024 | | 2024 |
| INPATIENT PALLIATIVE CARE USE IN CARDIAC ARREST COMPLICATING PULMONARY EMBOLISM AD Mehta, M Bansal, M Mehta, AA Pillai, S Vallabhajosyula Journal of the American College of Cardiology 83 (13_Supplement), 2629-2629, 2024 | | 2024 |
| POSTER: ABCL-529 The Difference in Mortality, Seroconversion, and Duration of Hospitalization Between Patients With and Without Anti-CD20 Antibody Therapy Among Hematological … CTR Vegivinti, R Thakur, J Shivakumar, MB Hammami, M Mehta, ... Clinical Lymphoma Myeloma and Leukemia 23, S203, 2023 | | 2023 |
| ABCL-529 The Difference in Mortality, Seroconversion, and Duration of Hospitalization Between Patients With and Without Anti-CD20 Antibody Therapy Among Hematological … CTR Vegivinti, R Thakur, J Shivakumar, MB Hammami, M Mehta, ... Clinical Lymphoma Myeloma and Leukemia 23, S440-S441, 2023 | | 2023 |
